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Summary
After basal cell carcinoma, the cutaneous squamous cell carcinoma (cSCC) is the second most frequent non-melanoma 
skin cancer worldwide, and, classically, arises from the upper coats of the epidermis of sun-exposed areas or from skin 
areas constantly exposed to a chronic inflammatory stimulus. The occurrence of cSCC seems to be linked to several factors, 
including exposure to sunlight (or other ultraviolet radiations), immunosuppression, chronic scarring conditions and some 
familial cancer syndromes. Although the majority of cSCCs are adequately eradicated by surgical excision, a subgroup 
of cSCC may be linked with an increased risk of recurrence, metastasis and death. The incidence of type 2 diabetes 
mellitus is constantly increasing worldwide. Importantly, diabetes mellitus is a strong risk factor for cancers (including 
cutaneous tumors) and is highly related with poor cancer outcomes. At present, in the literature, squamous cell carcinoma 
developing in association with diabetic foot ulcers has been already reported in some reports; however, additional 
data are needed to make the clinicians aware of this rare, although possible, complication. Therefore, we herein report 
an unusual case of an elderly man with T2DM and a positive oncological history, presenting a cSCC involving the skin 
overlying the first toe of left foot. The growing cSCC appeared approximately 3 years after the appearance of a diabetic 
ulcer.
Introduction
The cutaneous squamous cell carcinoma (cSCC) is 
estimated to be the second most frequent non-melanoma 
skin cancer worldwide (after basal cell carcinoma), as it 
represents 20–50% of all skin cancers (1, 2). Traditionally, 
cSCC appears from the higher coats of the epidermis of 
sun-exposed areas or from skin areas steadily exposed 
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Learning points:
 • Diabetic foot ulcers are an important and severe complication of diabetes mellitus and often can result in foot 
amputation.
 • Chronic and non-healing diabetic foot ulcers are often observed in clinical practice.
 • Clinicians should always take into consideration the malignant degeneration (e.g., cutaneous squamous cell 
carcinoma) of any chronic non-healing diabetic foot ulcer in elderly T2DM individuals.
 • Timely surgical resection of a chronic, non-healing diabetic foot ulcer might preclude the development of a 
cutaneous squamous cell carcinoma.
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to a chronic inflammatory stimulus (3, 4). Cutaneous 
squamous cell carcinoma often affects middle-aged or 
elderly individuals and males seem to be more affected 
than females (1, 2). Of note, although the most cases of 
cSCCs are adequately eradicated by surgical excision, a 
subgroup of cSCC could be associated with recurrence, 
metastasis and even death (3). The occurrence of cSCC is 
related to multiple factors, such as exposure to sunlight or 
other ultraviolet radiations, immunosuppression, human 
papillomavirus, chronic scarring conditions and some 
familial cancer syndromes (4).
To date, the total prevalence of type 2 diabetes 
(T2DM) is estimated to be nearly 8–9% of the adult 
population (approximately 420 million individuals) (5). 
Moreover, it is calculated that the overall prevalence of 
diabetes mellitus will rise to roughly 700 million in 2035 
and that approximately 75–80% of these individuals 
will live in developing countries (5). In addition to the 
increased risk of vascular and infectious disease (owing 
to T2DM), recent data strongly suggest that patients with 
T2DM have a higher risk of dying from cancer, including 
cutaneous tumors, compared to those without T2DM (6).
To date, in the literature, cSCC developing in 
association with a diabetic foot ulcer has been already 
described in some reports (7, 8, 9), but more information 
is required in order to make the clinicians aware of this 
rare (albeit possible) complication.
Therefore, we report herein an unusual case of an 
elderly man with T2DM and prior history of colon 
adenocarcinoma, presenting a cSCC involving the skin 
overlying the first toe of left foot. The growing cSCC 
occurred nearly 3 years after the appearance of a diabetic 
foot ulcer.
Case presentation
An 83-year-old Caucasian male patient with type 2 
diabetes (T2DM) came to our Diabetic Foot Clinic for the 
appearance of a traumatic ulcer at the apex of the first toe 
of his left foot in 2015 (Fig. 1, Panel A). The diagnosis of 
T2DM was made roughly 17  years ago and was treated 
with metformin with a good glycemic compensation. 
In addition to T2DM, his medical history included: 
hypertension, diabetic peripheral neuropathy and a prior 
history of colon adenocarcinoma eradicated by surgical 
excision followed by a treatment with capecitabine. A 
family history of cancer was not reported by the patient. 
As described previously, the ulcer at the apex of the first toe 
of left foot arose following a traumatic event (the patient 
said he had slammed into a bedroom furniture). At the 
beginning, the ulcer had been treated with a conservative 
approach by dressings with topical antiseptic and oral 
antibiotic therapy with amoxicillin-clavulanate, based 
on Staphylococcus aureus isolated by biopsy performed 
Figure 1
(Panel A) Initial presentation of the traumatic lesion located at the apex 
of the first toe of the left foot, in the subungual region beneath the 
toenail. (Panel B) Appearance of a red lobular lesion characterized by a 
friable consistency at the apex of the first toe (in the subungual region 
beneath the toenail) of the left foot appeared several years later.
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in an ambulatory setting. The blood tests showed 
white blood cells (WBC): 8.6 × 109/L (normal range: 
4.3–10), hemoglobin 124 g/L (normal range: 135–170), 
platelets: 331 × 100,000/mm3 (normal range: 150–450), 
fasting plasma glucose: 6.9 mmol/L (normal range: 
3.5–5.5), A1c: 47 mmol/mol (normal range: <42), alanine 
aminotransferase (ALT): 20 U/L (normal range: 6–50), 
gamma-glutamyl transpeptidase (GGT): 16 U/L (normal 
range: 4–60), creatinine: 73 µmol/L (normal range: 
53–115) and C-reactive protein (CRP): 8 mg/L (normal 
range: <5).
After 5 weeks, the ulcer completely healed. However, 
6 months later, the patient returned to our attention for 
the appearance of a new ulcer in the same area of the lesion 
described previously. The new lesion appeared pinkish, 
lobulated with a high tendency to bleeding. Apparently, 
there had not been any recent trauma that could explain 
such recurrence, but it is important to highlight that our 
patient had diabetic peripheral neuropathy, a condition 
that could conceal recurrent trauma owing to unsuitable 
footwear. Given the unusual characteristics of this lesion, 
we decided to perform a biopsy, which documented the 
presence of a pyogenic granuloma. As known, conservative 
surgical excision is the established choice of treatment 
for pyogenic granuloma and, therefore, we proposed to 
our patient a surgical excision, which he categorically 
refused. Given the unshakable decision of the patient, 
the subsequent management of the lesion was essentially 
made by local dressings (i.e., antiseptic and silver nitrate) 
(10) and use of specific shoes in order to offload the 
lesion. The patient was constantly informed regarding 
the need to perform a surgical excision, but he always 
refused. The conservative treatment (with dressings and 
offloading systems) has been going on for approximately 
18 months; a period wherein we observed a reduction of 
the size of the lesion followed by frequent recurrences. 
However, for the next 10  months, the patient followed 
no longer regular checks at our clinic, until he returned 
for the appearance of a red lobular lesion with a friable 
consistency at the apex of the first toe of the left foot, in 
the subungual region beneath the toenail (Fig.  1, Panel 
B). Again, the patient denied a recent trauma. The novel 
unusual appearance of the lesion as well as the detection 
of small calcifications on radiography (Fig.  2, Panel A) 
imposed the execution of a new incisional biopsy with 
subsequent histological examination, which revealed an 
infiltrate of monomorphic large cells in the dermis with 
prominent nucleoli and frequent mitoses, but without any 
vascular or perineural invasion. Immunohistochemical 
analysis showed a diffuse expression of CK5 and P40 
(Fig. 2, Panel B, C and D). The final diagnosis was an in 
situ cutaneous squamous cell carcinoma.
Treatment, outcome and follow-up
The clinical case was extensively discussed with oncologist 
and plastic surgeon who suggested the complete 
amputation of the toe. The ultrasound of the inguinal 
and the popliteal cavity did not reveal the presence of 
suspicious lymph nodes. Therefore, no further radiological 
examinations were performed.
Discussion
The cSCC is the one of the most common non-melanoma 
skin cancer worldwide and, typically, occurs from the 
upper layers of the epidermis of areas steadily exposed 
to a chronic inflammatory stimulus (1, 2). Importantly, 
although the majority cases of cSCCs are sufficiently 
eradicated through the surgical excision, a subset of cSCCs 
is linked to recurrence, metastasis and even death (3).
Classically, cSCC are examined by clinical 
examination and skin biopsy for histology (3). The 
biopsies can be excisional, where the entire lesion is 
removed, or incisional, in which a part of the lesion is 
excised. A biopsy provides a histopathological diagnosis. 
Subsequent investigations can be performed in some 
cases to assess extent of the disease and often include 
computed tomography imaging (in order to search for 
bone and soft tissue expansion) or MRI (in order to assess 
Figure 2
(Panel A) Small calcifications (white arrows) detected by radiography at 
the level of the first toe of the left foot. (Panel B) Histological findings of 
in situ cutaneous squamous cell carcinoma. (Panel C) 
Immunohistochemical analysis of CK5. (Panel D) Immunohistochemical 
analysis of p40.
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the extent of perineural invasion) (3). The main aim of 
the treatment for cSCC is the complete eradication of the 
tumor or metastases when possible (3). Therefore, the 
gold standard treatment for cSCC is surgery (3).
Our patient was an 83-year-old T2DM male with a 
positive oncological history and a chronic ulcer on his foot. 
Importantly, the appearance of suspected skin lesions in a 
T2DM patient with a positive oncological history requires 
much attention. An accurate evaluation of the patient 
is paramount in choosing the adequate therapeutic 
algorithm as well as the need for a multidisciplinary 
team. Given the unusual features of the foot lesion, the 
chronicity as well as the presence of calcification detected 
by radiography (which may be indicative of a chronic 
inflammatory process or a malignant degeneration), we 
decided to perform a histological investigation. We found 
an in situ cSCC with no characteristics of malignancy 
(Fig. 2, Panel B, C and D). Seeing that the inguinal and the 
popliteal cavity ultrasound did not reveal the presence 
of suspicious lymph nodes, we did not perform further 
radiological examinations.
To date, the physiopathology of cSCC is not completely 
understood. The cause seems to be multifactorial, 
including advanced age, sunlight or other ultraviolet 
radiations, immunosuppression, human papillomavirus, 
chronic scarring conditions and certain familial cancer 
syndromes (1, 2, 3). In our case, several risk factors for 
cSCC can be identified, such as old age, male sex, presence 
of T2DM, prior history of a colon adenocarcinoma and a 
chronic infection with possible recurrent trauma (which 
is frequently exacerbated by ill-fitting footwear in the 
presence of diabetic peripheral neuropathy). Familial 
cancer syndromes were not actively indagated.
Diabetes mellitus is strongly associated with insulin 
resistance and chronic inflammatory state, contributing to 
the local and systemic release of reactive oxygen species and 
several mediators, including interleukin-1 (IL-1), IL-6 and 
tumor necrosis factor-alpha (TNF-alpha) and tumor growth 
factor-beta (TGF-beta) (6). In addition, presently, there are 
data to indicate that all these (diabetes-related) mediators 
can promote development and progression of some 
cancers by cellular growth and proliferation, angiogenesis, 
inhibition of cellular apoptosis and DNA damage (6). 
Experimental studies also suggest that, compared to those 
without T2DM, patients with T2DM have a higher level 
of genomic instability and epigenetic alterations, that may 
concur to the development of cancer (6).
Similarly, repeated trauma or chronic infection is 
able to generate local inflammation with the release of 
several molecules, such as cytokines, prostaglandins and 
TGF-beta. The chronic inflammation may produce genetic 
and epigenetic changes, damaging DNA, inhibiting its 
repair, altering transcription factors, preventing apoptosis 
and stimulating angiogenesis, consequently concurring 
to the cancer formation (11, 12, 13). In addition, a 
positive oncological history (as in the case of our patient) 
may suggest the presence of a genome highly susceptible 
to develop multiple cancerous mutations. For instance, 
several studies have reported that patients with colorectal 
cancer may have important molecular alterations 
predisposing to genetic instability, such as chromosomal 
instability, deficient DNA mismatch repair and epigenetic 
silencing of key genes (14).
Notably, all these factors should guide the clinicians 
to make an appropriate and accurate assessment of a 
lesion if it does not heal, becoming chronic. In fact, timely 
surgical resection of a chronic, non-healing diabetic 
foot ulcer might ideally preclude the development of a 
cutaneous squamous cell carcinoma. Therefore, when a 
lesion does not heal within 8–12 months (after excluding 
the presence of other important concomitant conditions, 
including peripheral arteriopathy), a biopsy should be 
performed to exclude the presence of a neoplasm.
In conclusion, our case report corroborates and expands 
previous observations (7, 8, 9), reinforcing the notion 
that cSCC may be a serious (albeit rare) complication of 
the diabetic foot in elderly T2DM patients. The diagnosis 
of cSCC should always be considered and ruled out in a 
chronic non-healing lesion, especially in consideration of 
the latest risk factors for the development and progression 
of cSCC, in order to prevent a procrastination in the 
diagnosis and treatment and to improve outcome.
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